Utilising large and diverse bacterial genome datasets to improve the detection and identification of Streptococcus pneumoniae via PCR-based diagnostics
Ahlers FM. et al, (2025), Microbial Genomics
Identification of undetected SARS-CoV-2 infections by clustering of Nucleocapsid antibody trajectories.
Zwerwer LR. et al, (2025), Nature communications, 16
Timeliness of a potential automated system for national surveillance of healthcare-associated infections in England.
Quan TP. et al, (2025), The Journal of hospital infection
The impact of antimicrobial stewardship ward rounds on antimicrobial use and predictors of advice, uptake, and outcomes.
Eyre DW. et al, (2025), The Journal of infection
Addition of macrolide antibiotics for hospital treatment of community-acquired pneumonia.
Wei J. et al, (2024), The Journal of infectious diseases
Corrigendum to "No evidence of difference in mortality with amoxicillin versus co-amoxiclav for hospital treatment of community-acquired pneumonia" [J Infect 88 (2024) 106161].
Wei J. et al, (2024), The Journal of infection, 89
Machine learning and clinician predictions of antibiotic resistance in Enterobacterales bloodstream infections.
Yuan K. et al, (2024), The Journal of infection, 90
Developing a Framework for Tracking Antimicrobial Resistance Gene Movement in a Persistent Environmental Reservoir
Mathers A. et al, (2024), npj Antimicrobials and Resistance
Predicting individual patient and hospital-level discharge using machine learning.
Wei J. et al, (2024), Communications medicine, 4
Comparison of direct cDNA and PCR-cDNA Nanopore sequencing of RNA from <i>Escherichia coli</i> isolates.
Rodger G. et al, (2024), Microbial genomics, 10
Predicting future hospital antimicrobial resistance prevalence using machine learning.
Vihta K-D. et al, (2024), Communications medicine, 4
Expanding the use of mathematical modeling in healthcare epidemiology and infection prevention and control.
Grant R. et al, (2024), Infection control and hospital epidemiology, 1 - 6
Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050.
GBD 2021 Antimicrobial Resistance Collaborators None., (2024), Lancet (London, England), 404, 1199 - 1226
Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021.
GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators None., (2024), The Lancet. Infectious diseases, 24, 974 - 1002